Return to Home

Acelyrin, Inc.

SLRN

Find Out if You Qualify for a Financial Reward by filling out the form below.

Lead Plaintiff Deadline:
January 16, 2024

Days Left:
-492

calendar

Acelyrin, Inc. Form












Securities Fraud News does not share your information with others. There is no cost or obligation for you to submit.

Allegations

The filed complaint alleges that defendants made false statements and/or concealed that: (i) izokibep, the Company's lead product candidate, was less effective in treating Hidradenitis Suppurativa than defendants had led investors to believe; (ii) accordingly, Acelyrin overstated izokibep’s clinical and/or commercial prospects; (iii) as a result, Acelyrin also overstated the Company’s business prospects post-initial public offering; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

Eligibility

In order to be included in the lawsuit, you must have incurred a loss on shares of Acelyrin purchased or acquired during the class period listed above.

Lead Plaintiff Deadline

If you suffered a loss in Acelyrin during the relevant time frame, you have until January 16, 2024 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Find More Cases

Ticker Symbol Company Name Join Deadline
NSSC Napco Security Technologies, Inc. June 24, 2025 Join
NSSC Napco Security Technologies, Inc. June 24, 2025 Join
NSSC Napco Security Technologies, Inc. June 24, 2025 Join
CODI Compass Group Diversified Holdings, LLC July 08, 2025 Join
IOVA Iovance Biotherapeutics, Inc. July 14, 2025 Join